Beta-Glucan: Deeply hydrates, soothes sensitive skin and provides antioxidant protection against environmental stressors
These effects are not well-established in controlled human trials and should be considered speculative at this stage
The cost of peptides varies dramatically by compound, purity level, and source
299,300 Phase 2 trials of once weekly administration of the amylin receptor agonist, eloralintide, in adults with overweight or obesity and without type 2 diabetes have demonstrated significant weight loss, with a mean decrease in body weight ranging from 916%, compared with 0.4% in the placebo group.301 Combination therapy of amylin and semaglutide has also shown promise in weight management, with over 40% of trial participants achieving a decrease in body weight of 25%
Due to growing demand for capsule-based peptide formats, availability may be limited at times